findmyKOL
Clinical trialNCT03743298UnknownPhase 1Interventional

Safety of AV-MEL-1 With Anti-PD-1 Therapy in Metastatic Melanoma

SponsorAivita Biomedical, Inc.Enrollment20Metastatic Melanoma
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Jericho Rabago

    Irvine, California, United States

    Chaitali S Nangia, MD
    Recruiting
  • Hoag Memorial Hospital Presbyterian

    Newport Beach, California, United States

    Chaitali S Nangia, MD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
21 Apr 2021
Primary completion
31 May 2024
Completion
31 May 2026
Last update posted
10 Apr 2023
Registered enrollment
20
Registry id
NCT03743298
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.